Randomized Controlled Trial of Tacrolimus Versus Microemulsified Cyclosporin (TMC) in Liver Transplantation: Poststudy Surveillance to 3 Years
Authors:
Open Access
- 15 November 2006
- journal article
- research article
- Published by Elsevier in American Journal of Transplantation
- Vol. 7 (1) , 137-141
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- What determines the natural history of recurrent hepatitis C after liver transplantation?Journal of Hepatology, 2005
- RESULTS OF LIS2T, A MULTICENTER, RANDOMIZED STUDY COMPARING CYCLOSPORINE MICROEMULSION WITH C2 MONITORING AND TACROLIMUS WITH C0 MONITORING IN DE NOVO LIVER TRANSPLANTATIONTransplantation, 2004
- Cyclosporin A Suppresses Replication of Hepatitis C Virus Genome in Cultured HepatocytesHepatology, 2003
- Impact of immunosuppressive therapy on recurrence of hepatitis CLiver Transplantation, 2002
- Tacrolimus versus microemulsified ciclosporin in liver transplantation: the TMC randomised controlled trialThe Lancet, 2002
- Optimising immunosuppressionThe Lancet, 2002
- A LONG-TERM COMPARISON OF TACROLIMUS (FK506) VERSUS CYCLOSPORINE IN LIVER TRANSPLANTATION1Transplantation, 1998
- Three-year follow-up of the European multicenter tacrolimus (FK506) liver studyTransplantation Proceedings, 1997